|
|
|
|
| LEADER |
01786nam a22003855i 4500 |
| 001 |
000291147 |
| 005 |
20210915144124.0 |
| 007 |
cr nn 008mamaa |
| 008 |
171005s2017 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319658537
|
| 024 |
7 |
|
|a 10.1007/978-3-319-65853-7
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Sigma Proteins: Evolution of the Concept of Sigma Receptors /
|c edited by Felix J. Kim, Gavril W. Pasternak.
|
| 250 |
|
|
|a 1st ed. 2017.
|
| 260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2017.
|
| 300 |
|
|
|a VIII, 330 p. 64 illus., 32 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Handbook of Experimental Pharmacology,
|v 244
|
| 505 |
0 |
|
|a Preface -- Historical perspective and background - including Sigma protein subtypes and ligand selectivity -- Sigma imaging agents -- Medicinal chemistry -- 3-dimensional homology models of Sigma1 -- Neuronal plasticity and ion channels -- Opioid receptors and other GPCR -- Cancer -- Neurodegenerative diseases -- Pain -- Cognition, learning, neurological disorders -- Drug abuse and addiction -- Alcohol Abuse -- Stroke and neuroprotection.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
|
0 |
|a Human physiology.
|
| 650 |
|
0 |
|a Human genetics.
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
|
0 |
|a Pharmaceutical technology.
|
| 650 |
1 |
4 |
|a Neurosciences.
|
| 650 |
2 |
4 |
|a Human Physiology.
|
| 650 |
2 |
4 |
|a Human Genetics.
|
| 650 |
2 |
4 |
|a Cancer Research.
|
| 650 |
2 |
4 |
|a Pharmaceutical Sciences/Technology.
|
| 700 |
1 |
|
|a Kim, Felix J.
|e editor.
|
| 700 |
1 |
|
|a Pasternak, Gavril W.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|